Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell Transplantation
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if Darbepoetin alfa is effective in treating low red
blood cell levels after allogeneic stem cell transplant. Darbepoetin alfa has been shown to
help raise red blood cell levels without blood transfusions.